Access to National Market Share Data -CIRCANA
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $700,000 to $1,500,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Points of contact
-
- HFP Acquisition Liaison hfpacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is seeking access to national retail sales scanner data from CIRCANA covering the total U.S. market for the past five rolling years. This new requirement will enable the FDA to conduct ongoing post-market surveillance of packaged consumer goods and generate analyses to inform policy decisions. The solicitation is estimated to be released on October 1, 2025, with an anticipated award date of April 1, 2026.
The estimated award value ranges from $700,000 to $1,500,000 for this enterprise-level data access solution. The FDA intends to utilize this real-time post-market surveillance data to improve the accuracy and quality of research, publications, and post-market studies while identifying and tracking emerging public health benefits and threats related to FDA-regulated products. Inquiries regarding this opportunity should be directed to the FDA Acquisition Liaison at hfpacquisitions@fda.hhs.gov.
Forecast text
Access to National Market Share Data -CIRCANA
The objective of this acquisition is to obtain access to national retail sales scanner data from markets representing the total U.S. for the past 5 rolling years. The access will allow FDA to continue monitoring packaged consumer goods in the U.S. market and to enable analyses that will inform policy decisions. By acquiring data access, FDA shall obtain real-time access to post market surveillance data, improve the accuracy and quality of information included in post market studies, improve the accuracy and quality of research and publications, obtain a cost effective solution for access to supplemental post market data at an enterprise level, use the information to conduct post market surveillance on FDA regulated products to predict, identify and track emerging public health benefits and threats, use the information to initiate appropriate response to ensure the safety of FDA regulated products and the public.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast